×
SIGN UP FOR OUR MONTHLY NEWSLETTER

In 2019, we have access to two exciting new therapies

This past year brought some significant advances in eye care as far as new tests, technology, and drug approvals, and 2019 is looking just as promising. In 2018, we gained access to the first two new glaucoma drugs in decades. Now two more new drugs will soon be available to us. These include a new ocular corticosteroid that uses a revolutionary drug delivery technology, and a new drug that treats a rare and progressive eye disease that can lead to corneal scarring and vision loss. Here’s why I’m looking forward to trying these new therapies in my practice.Read More

New technology is on the horizon that can help you streamline your practice

New technologies are emerging that will transform ophthalmology and optometry. They may not be the ones that are on your radar, however. “While the eye care world has been fixated on telemedicine and online eye exams, robots are set to impact our 21st century world,” wrote Thomas A. Wong, O.D. in the Optometry Times.Read More

Patients want to know about eye-whitening drops, genetic tests, and new glaucoma drugs

It’s an exciting time to be an eye care practitioner. Advancements in diagnosis and treatment are happening all the time. Because patients are more engaged in their health and have access to more information than ever before, it’s important for doctors to stay on top on the latest developments.

Read More